Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 16626 - 16650 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Chromium	Approved Investigational	CYP1B1	1545	downregulated	Chromium results in decreased expression of CYP1B1 mRNA	2p22.2	A21641
Chromium	Approved Investigational	DDIT3	1649	upregulated	Chromium results in increased expression of DDIT3 mRNA	12q13.3	A21643
Chromium	Approved Investigational	DDX3Y	8653	downregulated	Chromium results in decreased expression of DDX3Y mRNA	Yq11.221	A21641
Chromium	Approved Investigational	DNER	92737	downregulated	Chromium results in decreased expression of DNER mRNA	2q36.3	A21641
Chromium	Approved Investigational	DSC2	1824	upregulated	Chromium results in increased expression of DSC2 mRNA	18q12.1	A21641
Chromium	Approved Investigational	DSC3	1825	upregulated	Chromium results in increased expression of DSC3 mRNA	18q12.1	A21641
Chromium	Approved Investigational	EIF1AY	9086	downregulated	Chromium results in decreased expression of EIF1AY mRNA	Yq11.223	A21641
Chromium	Approved Investigational	ELOVL7	79993	upregulated	Chromium results in increased expression of ELOVL7 mRNA	5q12.1	A21641
Chromium	Approved Investigational	ENPP1	5167	upregulated	Chromium results in increased expression of ENPP1 mRNA	6q23.2	A20678
Chromium	Approved Investigational	EPHA4	2043	upregulated	Chromium results in increased expression of EPHA4 mRNA	2q36.1	A21641
Chromium	Approved Investigational	EYA4	2070	downregulated	Chromium results in decreased expression of EYA4 mRNA	6q23.2	A21641
Chromium	Approved Investigational	F5	2153	downregulated	Chromium results in decreased expression of F5 mRNA	1q24.2	A20678
Chromium	Approved Investigational	FOS	2353	upregulated	Chromium results in increased expression of FOS mRNA	14q24.3	A21643
Chromium	Approved Investigational	FOSL1	8061	upregulated	Chromium results in increased expression of FOSL1 mRNA	11q13.1	A20678
Chromium	Approved Investigational	FURIN	5045	downregulated	Chromium results in decreased expression of FURIN mRNA	15q26.1	A20678
Chromium	Approved Investigational	GGCX	2677	downregulated	Chromium results in decreased expression of GGCX mRNA	2p11.2	A20678
Chromium	Approved Investigational	GPER1	2852	downregulated	Chromium results in decreased expression of GPER1 mRNA	7p22.3	A20678
Chromium	Approved Investigational	HHIP	64399	downregulated	Chromium results in decreased expression of HHIP mRNA	4q31.21	A21641
Chromium	Approved Investigational	HIST1H4C	8364	upregulated	Chromium results in increased expression of HIST1H4C mRNA	6p22.2	A20678
Chromium	Approved Investigational	HMGA1	3159	upregulated	Chromium results in increased expression of HMGA1 mRNA	6p21.31	A20678
Chromium	Approved Investigational	HMGCR	3156	downregulated	Chromium results in decreased expression of HMGCR mRNA	5q13.3	A20678
Chromium	Approved Investigational	HMGN2	3151	upregulated	Chromium results in increased expression of HMGN2 mRNA	1p36.11	A20678
Chromium	Approved Investigational	HNRNPH2	3188	downregulated	Chromium results in decreased expression of HNRNPH2 mRNA	Xq22.1	A20678
Chromium	Approved Investigational	IER2	9592	upregulated	Chromium results in increased expression of IER2 mRNA	19p13.13	A20678
Chromium	Approved Investigational	IGFL1	374918	downregulated	Chromium results in decreased expression of IGFL1 mRNA	19q13.32	A21641

Displaying entries 16626 - 16650 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability